BioLife Solutions Inc. earnings per share and revenue
On 06 nov 2025, BLFS reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 184.03% surprise. Revenue reached 28.07 millón, compared to an expected 26.21 millón, with a 7.10% difference. The market reacted with a -4.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -0.02 USD, with revenue projected to reach 24.56 millón USD, implying an reducir of -300.00% EPS, and reducir of -12.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08 ene 2026 para Q2 26
Estimar
$0.05
Actual
$0.10
Sorpresa
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08 ene 2026 para Q2 26
Estimar
-$0.20
Actual
-$0.41
Sorpresa
-100.98%
Preguntas frecuentes
What were BioLife Solutions Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BioLife Solutions Inc. reported EPS of $0.01, beating estimates by 184.03%, and revenue of $28.07M, 7.1% above expectations.
How did the market react to BioLife Solutions Inc.'s Q3 2025 earnings?
The stock price moved down -4.03%, changed from $27.02 before the earnings release to $25.93 the day after.
When is BioLife Solutions Inc. expected to report next?
The next earning report is scheduled for 02 mar 2026.
What are the forecasts for BioLife Solutions Inc.'s next earnings report?
Based on 12
analistas, BioLife Solutions Inc. is expected to report EPS of -$0.02 and revenue of $24.56M for Q4 2025.